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Purpose: To evaluate different methods of oxacillin susceptibility testing of ocular
isolates, considering polymerase chain reaction (PCR) as the ‘gold standard’, and
to compare the in vitro susceptibility to oxacillin with that of other antimicrobials
used in ophthalmologic practice. Methods: The Vitek gram-positive identification
card was used to identify ocular coagulase negative Staphylococcus species. The
presence of the mecA gene was determined by the polymerase chain reaction assay
with a combination of two primer sets (mecA and 16S rRNA) in a single region.
Results were analyzed and compared with other oxacillin susceptibility methods:
PBP2a detection by rapid slide latex agglutination test (SLA); oxacillin E-test; the
Vitek automated gram-positive susceptibility card (GPS-105); the oxacillin salt agar
screening test (OSAS) at a concentration of 6.0, 1.0 and 0.75 μg oxacillin per ml and
the cefoxitin disk diffusion test (CDD). Automated susceptibility was also determined
to other antimicrobial agents (fluoroquinolones, penicillin G, amoxicillin-ampicillin,
cefazolin, ampicillin-sulbactam, erythromycin, clindamycin, gentamicin, tetracycline,
trimethoprim-sulfamethoxazole, vancomycin and rifampin. Results: Of the 69
CoNS isolates tested, 71% were mecA-positive and 29% mecA-negative. All
methods tested had a statistically significant agreement with polymerase chain
reaction. There was a tendency of positive polymerase chain reaction predomination
among the S. epidermidis isolates in comparison to non-epidermidis isolates,
although this was not statistically significant (78.3% vs. 56.5%; χ2= 2.54; P= 0.11).
The oxacillin salt agar screening test (0.75 µg oxacillin/ml) showed the best
performance, with 100% sensitivity and negative predictive value; 95% specificity
and 98% positive predictive value. Using the E-test, the mecA-positive isolates were
statistically significantly more resistant to ciprofloxacin, ofloxacin, gatifloxacin and
moxifloxacin (P= 0.002; P= 0.008; P= 0.002 and P= 0.003, respectively). There was
a statistically significant higher proportion of resistance of the coagulase negative
Staphylococcus mecA-positives for: penicillin G, amoxicillin-ampicillin, cefazolin,
ampicillin-sulbactam, erythromycin, clindamycin, gentamicin and tetracycline
(P≤0.05). All coagulase negative Staphylococcus species were susceptible to
vancomycin and there was no statistically significant correlation between the mecA-
positive isolates and resistance to trimethoprim-sulfamethoxazole or to rifampin.
Conclusions: In the present study, we found that the E-test and the oxacillin salt
agar screening test S (0.75 μg oxacillin per ml), when compared with polymerase
chain reaction, were the most accurate currently available methods to phenotypically
detect oxacillin resistance of coagulase negative Staphylococcus species. This study
demonstrated that a good option for screening of ocular isolates for oxacillin
resistance in the microbiology laboratory is the cefoxitin disk diffusion test and the
automated Vitek system. We believe it is important to have available methods that
accurately detect methicillin resistance of the less commonly encountered species,
chiefly because of their increasing importance as opportunistic pathogens.
ABSTRACT
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INTRODUCTION
Coagulase-negative Staphylococcus (CoNS) species are
commonly isolated bacteria, often admixed with more typical
ocular microbes, and can lead to major infections, including
keratitis, conjunctivitis and endophthalmitis(1-3). Staphylo-
coccus epidermidis, the predominant species of the CoNS, is
the most commonly cultured intraocular pathogen, and ac-
counts for an average of 40% postoperative and posttrauma-
tic endophthalmitis cases(4-5).
Methicillin-resistant coagulase negative Staphylococcus
(MRCoNS) is just one species of intraocular pathogens(6) and
one report in the literature has described patients with MR-
CoNS among the preoperative ones seen at a Japanese eye
clinic(7). Resistance to methicillin is associated with in vitro
crossing resistance to other antimicrobials(6,8). The laboratory
data from the Ophthalmological Department of the University
of São Paulo (UNIFESP) has documented a recent increase in
infections due to this microorganism(9). In contrast to infec-
tion at other sites, the ocular therapeutic difficulties posed by
the MRCoNS have been virtually unrecognized.
Two basic mechanisms are responsible for the resistance
of staphylococci to the beta-lactamic antimicrobials: first, the
β-lactamase production that destroys these agents, and, se-
cond, alteration of proteins located in the cellular wall of the
bacteria, the so-called penicillin-binding proteins (PBPs)(10).
Most resistance to oxacillin by staphylococci is mediated by
the mecA gene, which codes for the production of a supple-
mental penicillin-binding protein, PBP2a or 2’, which is expres-
sed either homogeneously or heterogeneously(11-12). PBP2a
has a low affinity for beta-lactamic antimicrobials. Homoge-
neous resistance is easily detected with standard testing me-
thods, whereas heterogeneous expression is more difficult to
detect with some methods, because only a fraction of the
population (e.g., 1 in 100,000 cells) expresses the resistance
phenotype(13).
Tests for mecA or for the protein encoded by mecA, PBP2a,
are the most accurate methods for prediction of resistance to
oxacillin, and could be used to confirm results of staphylo-
cocci isolates from serious infections(14). Oxacillin is no longer
the agent recommended by the Clinical and Laboratory Stan-
dards Institute (CLSI; formerly the National Committee of
Clinical and Laboratory Standards - NCCLS) for CoNS pheno-
typic tests to predict resistance to penicillinase-stable penicil-
lins (PSPs). Antimicrobial susceptibility tests using oxacillin
are often difficult to interpret, despite changes that have im-
proved discrimination between oxacillin-susceptible and -
resistant strains. Minimum inhibitory concentration (MIC) pa-
nels in which oxacillin is tested must be examined carefully to
detect any growth that may be indicative of resistance(13-16).
Several groups of investigators(17-19) have reported that the
results of cefoxitin (30 μg) disk diffusion tests correlate better
with the presence of mecA than do the results of disk diffusion
tests using oxacillin, and the cefoxitin disk test is now the
preferred method for testing CoNS(13).
The oxacillin salt agar screen (OSAS) has been recom-
mended by CLSI (2005) as an additional test that can be used
if the dilution tests or disk diffusion tests are indeterminate.
However, the agar screen test is recommended only for S.
aureus, and it also can be difficult to read, especially if the
isolate is heteroresistant(20-21).
The purpose of the study described herein was to evaluate
different oxacillin susceptibility methods currently used for
ocular isolates, considering the multiplex PCR assay for detec-
tion of the mecA gene to be the ‘gold standard’, and to compa-
re the susceptibility of mecA-positive CoNS with mecA-nega-
tive CoNS to other antimicrobials used in ophthalmic practice:
fluoroquinolones, penicillin G, amoxicillin-ampicillin, cefazo-
lin, ampicillin-sulbactam, erythromycin, clindamycin, gentami-
cin, tetracycline, trimethoprim-sulfamethoxazole, vancomycin
and rifampin.
METHODS
Bacterial isolates and bacteriologic methods
Fresh and cryopreserved bacterial isolates were used.
They were collected between July 2002 and July 2004 and
processed according to standard microbiologic protocols in a
reference ophthalmological laboratory. Samples included 69
CoNS isolates from clinically diagnosed keratitis, conjunc-
tivitis or endophthalmitis. The laboratory had identified the
organisms as CoNS by colony morphology, Gram stain cha-
racteristics, and by catalase and coagulase tests. S. aureus
(ATCC 25923) was used as the mecA gene negative control
and S. aureus (ATCC 43300) was used as the mecA gene
positive control.
Inoculum preparation
Inocula for all tests were prepared using trypicase soy
agar (TSA) (Difco, Le Pont de Claix, France) supplemented
with 5% sheep blood that had been streaked with a single
colony from an initial subculture plate and incubated for 18 to
24 h. The test inoculum was prepared by removing growth
from the agar plate, inoculating it directly into Mueller-Hinton
broth (MHB) (Difco, Le Pont de Claix, France), and adjusting
the inoculum to equal a 0.5 McFarland turbidity standard.
Identification of species
The Vitek (BioMerieux, Hazelwood, MI) gram-positive iden-
tification card was used to identify the CoNS species. Card
inoculation, sealing, incubation, and reading were performed
according to the instructions of the manufacturer. The species
were then classified into two groups: epidermidis (S. epider-
midis CoNS) and non-epidermidis (CoNS non-S. epidermidis).
Polymerase chain reaction (PCR) detection of mecA gene
The mecA gene, in combination with the 16S rRNA gene,
was detected with a PCR technique based on the procedure
described previously(22). The multiplex assay combined two
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primer sets (mecA and 16S rRNA) in a single region, and
presence of the mecA gene was considered the ‘gold stan-
dard’ for oxacillin resistance.
PBP2a latex slide agglutination test (LSA)
Penicillin-binding protein 2a detection by the rapid slide
latex agglutination test (Slidex MRSA Detection Test, Bio-
Merieux, Paris, France) was performed according to the manu-
facturer’s instructions with slight modification: the resulting
agglutination pattern was read at 10. Bacterial cells (approxi-
mately 5 µl) were obtained from a fresh subculture and sus-
pended in 4 drops of extraction reagent 1 and boiled for 3 min.
The suspension was allowed to cool to room temperature,
after which 1 drop of extraction reagent 2 was added, and the
mixture vortexed thoroughly. The suspension was then centri-
fuged at 1500 x g for 5 min. A 50 µl aliquot of the supernatant
was mixed with 1 drop of anti-PBP2a monoclonal antibody-
sensitized latex beads. A negative control test was performed
by using 50 µl of supernatant mixed with 1 drop of negative
control latex. The isolates were then placed on a shaker and
gently mixed for up to 15 mins.
Automated susceptibility test (AS)
The AS test was performed with the Gram-Positive Suscep-
tibility card (GPS-105) of the Vitek system (BioMerieux, Hazel-
wood, MI), according to the manufacturer’s recommendation.
The susceptibility of all CoNS isolates was determinated for
oxacillin and the other antimicrobials used in ophthalmology:
penicillin G, amoxicillin-ampicillin, cefazolin, ampicillin-sul-
bactam, erythromycin, clindamycin, gentamicin, tetracycline,
trimethoprim-sulfamethoxazole, vancomycin and rifampin.
Oxacillin salt agar screen susceptibility test (OSAS)
Agar screen tests for susceptibility to oxacillin were per-
formed by a method described previously(23). The OSAS test
was performed with agar plates produced by PROBAC (São
Paulo, Brazil). A total of 104 CFU was spot inoculated onto
Mueller-Hinton agar (MHA) (PROBAC, São Paulo, Brazil) with
4% NaCl supplementation containing 6, 1 or 0.75 µg of oxa-
cillin per ml. Plates were read after a 24 h incubation at 35ºC. If
any colonies of growth were detected, the test was considered
to be positive for resistance.
Disk susceptibility test (DD)
The CLSI reference method for disk diffusion was used to
test cefoxitin (30 µg) (Oxoid, Basingstore, England)(13). MHA
plates were incubated at 35ºC, and zone diameters were read at
18 h to 24 h.
E-test
The minimum inhibitory concentrations (MIC) for oxacillin,
ciprofloxacin, ofloxacin, gatifloxacin and moxifloxacin were
each determinated using the E-test (AB Biodisk, Solna, Swe-
den). Plates were incubated at 35ºC for 18 to 24 hours. The
MIC value (E-test) was read at the point where the edge of the
growing culture intersects the strip. The antimicrobial suscep-
tibility of each bacterial isolate was determined by comparing
the MIC with that of the Clinical and Laboratory Standards
Institute (CLSI)(14) when available. Each isolate was classified
as susceptible or nonsusceptible (intermediate or resistant).
β-Lactamase test
β-Lactamase production was identified using nitrocefin
disks (Difco, Le Pont de Claix, France). This test was perfor-
med with all mecA-negative isolates that were resistant by E-
test or by the automated method.
Amoxicillin-clavulanic acid disk diffusion test
The amoxicillin-clavulanic acid disk test (20 µg amoxicillin
and 10 µg clavulanic acid) (Oxoid,Basingstore, England) was
performed with all mecA-negative isolates that were found to
be resistant by E-test or by the automated method. The break-
point for susceptibility was a zone of inhibition ≥20 mm in
diameter after 24 h of incubation at 30ºC.
Data analysis
Evaluation of data comparing results of the mecA gene
PCR assay and results from the other susceptibility tests
required a matched 2-by-2 table. Evaluation of data was calcu-
lated using the SPSS (Statistical Package for Social Sciences,
11.0 version, SPSS Inc, Chigaco). Difference in susceptibility
methods and significance of the results was calculated by the
Chi-square test or Fisher exact test. Statistical significance
was accepted when the P-value was <0.05. Validity tests (sen-
sitivity, specificity, positive predictive value and negative
predictive value) were also calculated. Sensitivity was defined
as the percentage of mecA-positive isolates determined to be
nonsusceptible by phenotypic testing, and specificity was
defined as the percentage of mecA-negative isolates deter-
mined to be susceptible by phenotypic testing. The isolates
were designated as susceptible or nonsusceptible (resistant
and intermediate) based on the 2006 CLSI document.
RESULTS
Of 69 CoNS tested, 49 (71%) were mecA-positive and 20
(29%) were mecA-negative. They were classified into one of
two groups based on species identification: 46 (66.7%) were S.
epidermidis and 23 (33.3%) were non-epidermidis (9 S. auri-
cularis; 4 S. haemolyticus; 4 S. capitis; 2 S. simulans; 1 S.
hominis; 1 S. sciuris, 1 S. cohnii and 1 S. saprophyticus). For
the mecA-negative isolates only the 16S rRNA specific band
was observed.
All methods tested had a statistically significant agree-
ment with PCR (Table 1). Table 2 shows the results of oxacillin
susceptibility tests for each of the 69 CoNS isolates.
All mecA-positive isolates were oxacillin resistant by the
E-test, although three isolates that were resistant by the E-test
did not show the mecA gene. In the automated method, four
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resistant isolates did not show the mecA gene, although they
were positive by the nitrocefn disk test and were susceptible
to amoxicillin-clavulonic acid disks. Only 46 mecA-positives
showed latex agglutination (κ=0.90; P<0.001). All mecA-posi-
tives were detected by the agar screen test with 0.75 oxacillin
μg/ml, although, one and six isolates had not being detected
by the agar screen test with 1 and 6 oxacillin μg/ml respecti-
vely (κ=0.96; κ=0.97;κ=0.87; P<0.001 respectively). The cefo-
xitin disk diffusion test did not show resistance in 5 mecA-
positive isolates (κ=0.84; P<0.001).
Validity of results for all methods tested is shown in table
3. The agar screen oxacillin test (0.75 µg/ml) showed the best
performance with results of 100% sensitivity and negative
predictive value, and 95% specificity and 98% positive predic-
tive value. When comparing the epidermidis with the non-
epidermidis groups, the latter had the worst values regarding
sensitivities in the latex, automated, agar screen (6 and 1 µg/ml)
and cefoxitin disk diffusion tests, and in specificities of the E-
test and agar screen (0.75 µg/ml) tests (Table 4).
There was a tendency toward mecA predominance among
the S. epidermidis compared to non-epidermidis groups, al-
though the difference was not statistically significant (78.3%
vs. 56.5%; χ2=2.54; P = 0.11) (Figure 1). For the non-epidermi-
dis group, there were more false-positives in the E-test, auto-
mated method and the agar screen test with 0.75 oxacillin μg/
ml, and more false-negatives in the automated method, ce-
foxitin disk diffusion test and the the agar screen test with 1
oxacillin μg/ml than for the epidermidis group. For the epider-
midis group, there were more false negatives for the latex
agglutination test (Table 5).
By the E-test, the mecA-positive isolates were statistically
significantly more resistant to ciprofloxacin, ofloxacin,
gatifloxacin and moxifloxacin (P=0.002; P=0.008; P=0.002 and
P=0.003) (Figure 2).
There was a statistically significant higher proportion of
resistance of the CoNS mecA-positives to penicillin G, amoxi-
cillin-ampicillin, cefazolin, ampicillin-sulbactam, erythro-
mycin, clindamycin, gentamicin and tetracycline (P≤0.05).
Resistance to vancomycin was not observed. There was no
statistically significant correlation between the mecA-positive
isolates and resistance for trimethoprim-sulfamethoxazole or
rifampin (Figura 3).
In comparing the two species groups, there was a statisti-
cally significant higher proportion of resistance of the S. epi-
dermidis than of the non-epidermidis groups to cefazolin and
to ampicillin-sulbactam (P=0.05 and P=0.05, respectively); the
S. epidermidis isolates were also more resistant to fluoroqui-
nolones, penicillin G, amoxicillin-ampicillin, erythromycin,
clindamycin, gentamicin, trimethoprim-sulfamethoxazole and
rifampin (although with no statistical significance).
Table 1. Comparison of PCR and others oxacillin susceptibility
tests (agreement)
Test Agreement (κ) ρ
Latex agglutination 0.90 <0.001
Oxacillin E-test 0.89 <0.001
Automated susceptibility 0.78 <0.001
Agar screen (0.75 µg/ml) 0.96 <0.001
Agar screen (1.0 µg/ml) 0.97 <0.001
Agar screen (6.0 µg/ml) 0.87 <0.001
Cefoxitin disk diffusion 0.84 <0.001





Latex agglutination 33.3% 66.7%
Oxacillin E-test 24.6% 75.4%
Automated susceptibility 26.1% 73.9%
Agar screen (0.75 µg/ml) 27.5% 72.5%
Agar screen (1.0 µg/ml) 30.4% 69.6%
Agar screen (6.0 µg/ml) 34.8% 65.2%
Cefoxitin disk diffusion 36.2% 63.8%
cipro= ciprofloxacin nonsusceptible; oflox= ofloxacin nonsusceptible;
gati= gatifloxacin nonsusceptible; moxi= moxifloxacin nonsusceptible
Figure 2 - Comparison between the mecA-positive and fluoroquinolone
nonsusceptible vs. mecA-negative and fluoroquinole nonsusceptible
isolates percentages
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(i.e., medium, inoculum size, pH, temperature, and salt concen-
tration)(27-28). Only a few cells in a population of bacteria may
be PBP2a positive because of heterogeneity of mecA gene
DISCUSSION
Staphylococci are the most commonly pathogens isolated
from ocular tissues(1-2,5,24). Because of their ubiquitous nature
and relatively low virulence, staphylococci, other than S. au-
reus, in the past were often simply reported by the microbio-
logy laboratory as CoNS. However, over the past 15 years,
there has been increased documentation of ocular infections
caused by CoNS(1,5-6,9,25-26). Because the antimicrobial suscep-
tibility of CoNS is unpredictable, and because multiresistant
isolates are common, the recommendation now is to perform
antimicrobial susceptibility testing in all cases of clinically
significant ocular infections caused by these organisms.
Identification of methicillin-resistant staphylococci in the
laboratory is complicated by the heterogeneous nature of the
resistance and by the variables that influence its expression
Table 3. Validity tests for the oxacillin susceptibility test (PCR as gold standard)
Test Sensitivity (%) Specificity (%) PPV (%) PNV (%)
Latex agglutination  93.9 100.0 100.0  87.0
Oxacillin E-test 100.0  85.0  94.2 100.0
Automated susceptibility  95.9  80.0  92.2  88.9
Agar screen (0.75 µg/ml) 100.0  95.0  98.0 100.0
Agar screen (1.0 µg/ml)  98.0 100.0 100.0  95.2
Agar screen (6.0 µg/ml)  91.8 100.0 100.0  83.3
Cefoxitin disk diffusion  89.8 100.0 100.0  80.0
PPV= predictive positive value; PNV=  predictive negative value
Table 4. Validity of the oxacillin susceptibility test (PCR as ‘gold standard’), comparing the epidermidis and non-epidermidis groups
Test Sensitivity (%) Specificity (%)
Epidermidis Non-epidermidis Epidermidis Non-epidermidis
Latex agglutination  94.6 91.7 100.0 100.0
Oxacillin E-test 100.0 100.0 90.0 80.0
Automated susceptibility 100.0 83.3 80.0 80.0
Agar screen (0.75 µg/ml) 100.0 100.0 100.0 90.0
Agar screen (1.0 µg/ml) 100.0 91.7 100.0 100.0
Agar screen (6.0 µg/ml) 94.6 83.3 100.0 100.0
Cefoxitin disk diffusion 94.6 75.0 100.0 100.0
Table 5. False-positives and false-negatives, according to species
groups, for oxacillin susceptibility tests
Test Epidermidis (%) N-epidermidis (%)
FP FN FP FN
Latex agglutination  0.0  16.7  0.0  9.1
Oxacillin E-test  2.7  0.0  13.3  0.0
Automated susceptibility  5.3  0.0  15.4  20.0
Agar screen (0.75 µg/ml)  0.0  0.0  7.1  0.0
Agar screen (1.0 µg/ml)  0.0  0.0  0.0  9.1
Agar screen (6.0 µg/ml)  0.0  16.7  0.0  16.7
Cefoxitin disk diffusion  0.0  16.7  0.0  23.1
FP= false-positive; FN= false-negative
Pen G= penicillin G nonsusceptible; amp/amox= amoxicillin-ampicillin
nonsusceptible; cefazolin= cefazolin nonsusceptible; amp/sub= ampicillin-
sulbactam nonsusceptible; erythro= erythromycin nonsusceptible; clinda=
clindamycin nonsusceptible; genta= gentamicin nonsusceptible; tetra=
tetracycline nonsusceptible; trim-sulfa= trimethoprim-sulfamethoxazole
nonsusceptible; vanco= vancomycin nonsusceptible and rifamp= rifampin
nonsusceptible.
Figure 3 - Comparison between the group mecA+ (isolates that were
mecA-positive and nonsusceptible for each of the other antimicrobial
drugs) vs. the group mecA- (isolates that were mecA-negative and non-
susceptible for each of the other antimicrobial drugs)
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expression, especially in CoNS(29). Furthermore, methicillin
resistance can involve non-PBP2a-dependent mechanisms,
such as hyperproduction of β-lactamase(30).
Several studies have demonstrated that PCR is a sensitive
method for the detection of methicillin resistance in CoNS(22,31).
Unfortunately, most laboratories, especially ophthalmologic
ones, are not in a position to perform this test. The percentage
of mecA-positive cultures and the predominance of S. epider-
midis in the eye was similar to findings at other sites(29,32-37). A
multicenter study in Brazil showed methicillin resistance in
87.7% of CoNS isolated from infections of the bloodstream(38).
Previous studies that examined results of the GPI card (auto-
mated Vitek system), have reported CoNS identification to vary
from 67.3% to 89%. These discrepant results in identification
are related to species that are less commonly isolated, while the
system was quite reliable for the most commonly isolated and
more clinically relevant species: S. epidermidis(37,39-42).
All of the oxacillin susceptibilities tests performed in this
study were in overall agreement with PCR results, and the
phenotypic methods evaluated in the present study also ap-
peared to perform well for the detection of oxacillin resistance.
The LSA test was done with extension of the reaction time
to 10 min, with resultant 93.9% sensitivity; this is not as good
a result as that reported in the literature, which describes the
use of oxacillin-induced colonies(34,43) or the use of a greater
concentration of inoculum(44-45). This test has the advantage
of having a short turnaround time, but it was the most expen-
sive test performed and failed to detect oxacillin resistance in
3 (6.1%) mecA-positive CoNS isolates.
The cefoxitin disk test is rapidly becoming the preferred me-
thod for for the detection of oxacillin heteroresistance(19,46-47).
This test is easier to read, has higher specificity than and
equal sensitivity to the oxacillin disk test for CoNS(46). The
specificity in this study was 100%; the sensitivity, however,
although similar to that reported in the literature (range, 85%
to 96%)(19), showed a decrease in overall percentage rate
because results for the non-epidermidis group were worse
than were those for the epidermidis group.
In this version of the automated test, detection of methi-
cillin resistance was based solely on determination of oxacillin
MIC. The literature reports high sensitivities (range, 95.7% to
100%) but only a moderate degree of specificity (range, 61% to
91.8%) for the Vitek system (first version) with CoNS, similar
to our results(34,44-45,48-49). Compared to the more conventional
phenotypic methods, which can take up to 24 h, the automated
test provides results in about 10 hs, which may have a poten-
tial impact on the optimal management of CoNS infections.
Additionally, it is easy to use and is relatively inexpensive
because of reduced laboratory expenses and other general
costs. The reduced specificity encountered in our study may
be attributable to the high oxacillin MICs for mecA-negative
non-epidermidis isolates(49). The MIC breakpoints were found
to be less accurate when they were applied to some species of
CoNS, and our findings confirm this observation(49) (Table 3).
Four of the false-positive isolates were β-lactam hyperprodu-
cers, which was confirmed by the nitrocefin and amoxicillin-
clavulonic acid disk diffusion tests.
Although it has been reported(27) that OSAS (6.0 µg/ml) is
ineffective for CoNS, the OSAS (0.75 µg/ml) in the present
study showed the best performance of all of the used tests,
including the other two concentrations (1.0 and 6.0 µg/ml), and
it could thus be considered an accurate method for confirmation
of resistance. Comparative studies to assess the OSAS and disk
diffusion test have shown that OSAS has good sensitivity for
the identification of methicillin-resistant strains(29,33,36,45,50-52).
The E-test and OSAS (0.75 µg/ml) were equally reliable in
their detection of mecA-positive isolates. However, these me-
thods proved to be less accurate in discerning isolates that
lacked the mecA gene. Louie et al.(45) found a relatively low
level of specificity (78%) for the E-test, similar to what we
noted. By the E-test and OSAS oxacillin (0.75 µg/ml), 3 (1 S.
epidermidis, 1 S. auricularis and 1 S. haemolyticus) of 20
(15%) and 1 (S. auricularis) of 20 (5%) mecA-negative isolates
appeared to be resistant. Again, the new breakpoints values,
reported by Tenover et al.(27), in 1999, were chosen because
they were the best for maximizing the sensitivity of detection
of mecA-positive S. epidermidis isolates without severely
compromising specificity. However, for CoNS other than S.
epidermidis, the actual breakpoints are less effective in diffe-
rentiating mecA-positive from mecA-negative isolates. Rowe
et al.(23), indicated that, for S. epidermidis, the E-test and the
OSAS (0.6 µg/ml) correctly discriminated mecA-positive from
mecA-negative isolates with 100% sensitivity. However, these
tests were not satisfactory to assess methicillin resistance to
other CoNS species. Our study showed 100% sensitivity of
the E-test and OSAS (0.75 µg/ml) for both groups (epider-
midis and non-epidermidis), but there were differences in
OSAS 1 and 6 µg/ml for the two groups (100% vs. 91.7% and
94.6% vs. 83.3%, respectively). There were also differences in
the latex agglutination, automated and cefoxitin disk diffusion
tests. The present study used only 23 of the non-epidermidis
CoNS species, and a greater number would be required for
validation of the interpretation.
The false-negative results in the tests evaluated may be due
to an extremely heterogeneous expression of resistance(53). On
the other hand, the false-positive results may have been the
result of overproduction of penicillinase, or of superexpres-
sion/alterations of constitutive PBPs. It is known that peni-
cillinase-resistant penicillins may show some degree of lysis
when such enzymes are present. The superexpression or alte-
ration of constitutive PBPs generates a higher concentration
of free transpeptidase, which synthesize the cell wall of the
bacteria(53). The expression of resistance is enhanced by pas-
sage in β-lactam antimicrobials, because the susceptible sub-
population is eliminated and the highly resistant subpopu-
lation is selected out. These antimicrobial-selected cells are
therefore more uniformly resistant than is the parent strain,
but the trait is unstable. With repeated subculturing in drug-
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free medium, the culture reverts to its heterogeneous pattern
of resistance(52). Attempts to increase sensitivity for detection
of methicillin resistance may do so at the cost of reduced
specificity. Factors that enhance such resistance (48-h incu-
bation, 5% NaCl, 30ºC incubation, and high doses of inocu-
lum) may also enhance β-lactamase production(52).
Methicillin-resistant staphylococci are typically resistant
to a variety of antimicrobials, including quinolones, tobramy-
cin, clindamycin, trimethoprim-sulfamethoxazole, tetracycline,
and erythromycin(52,54). Therefore, before any drug other than
vancomycin is used, susceptibility of the isolate must be
confirmed(24). Hussain et al.(34), in 2002, affirmed that CoNS
with the mecA gene were resistant to erythromycin, clinda-
mycin and co-trimoxazole, but that tetracycline was equally
active against mecA-positive and mecA-negative isolates; no
resistance was observed for vancomycin(34). It has also been
reported that in vitro susceptibility of CoNS to fluoroqui-
nolone antimicrobials is higher for the methicillin-resistant
group then for the methicillin-susceptible group, and both
groups of staphylococci are more susceptible to gatifloxacin
and moxifloxacin than to ciprofloxacin and ofloxacin(55). The
data show higher potency of the fourth generation of
fluoroquinolones to treat these infections than that of the
second generation(56-58).
CONCLUSION
In conclusion, because the E-test and the OSAS using
0.75 μg oxacillin per ml, compared with PCR, were the most
accurate available phenotypic methods of detecting oxacillin
resistance in CoNS ocular isolates, we recommend these tests
to confirm results on ocular specimens, since many laborato-
ries, especially those dedicated to ophthalmologic purposes
cannot afford to perform PCR. A good option for the scree-
ning of oxacillin resistance is the cefoxitin disk diffusion test
and the automated test. The differences observed in the oxa-
cillin susceptible tests for CoNS may be explained by the fact
that CLSI/NCCLS does not take into consideration the species
of the isolated bacterium. Because of their increasing impor-
tance, clinically significant CoNS should be identified to the
species level and should have their antimicrobial suscepti-
bility profiled. Further studies also may better define the
breakpoints for methicillin resistance in CoNS other than S.
epidermidis. These steps should improve our knowledge of
the role played in clinical ophthalmology diseases by this
group of bacteria, and aid clinicians in the treatment and
alleviation of patient suffering and morbidity. The generic
identification “coagulase negative staphylococci” may be
inappropriate, as it ‘lumps’ together species that respond
differently to the same experimental conditions with respect to
mecA gene detection. Not surprisingly, mecA-positive CoNS
were more resistant to the other antimicrobials than were
mecA-negative CoNS that are widely used in ophthalmology
and were tested in the present study.
RESUMO
Objetivos: Avaliar os diferentes métodos de suscetibili-
dade à oxacillina, em isolados oculares, considerando a reação
em cadeia da polimerase (PCR) como “padrão-ouro” e compa-
rar a suscetibilidade in vitro para outros antimicrobianos de
uso oftalmológico. Métodos: O sistema automatizado Vitek foi
utilizado para identificar as diferentes espécies de Staphylo-
coccus coagulase negativo (SCoN). A presença do gene mecA
foi determinado pela reação em cadeia da polimerase com a
combinação de 2 “primer” sets (mecA e 16S rRNA) em uma
única região. Estes resultados foram analisados e comparados
com outros métodos de suscetibilidade à oxacilina: detecção
da proteína PBP2a pelo teste de aglutinação em látex (SLA); E-
test oxacilina; o sistema automatizado Vitek (GPS-105); o teste
de triagem em ágar (OSAS) com oxacilina nas concentrações
de 6,0, 1,0 e 0,75 μg oxacilina por ml e o teste de disco difusão
com cefoxitina (CDD). A suscetibilidade automatizada foi obti-
da para os seguintes agentes antimicrobianos: fluorquinolo-
nas, penicilina G, amoxicilina-ampicilina, cefazolina, ampici-
lina-sulbactam, eritromicina, clindamicina, gentamicina, tetra-
ciclina, sulfametoxazol-trimetoprima, vancomicina e rifampi-
cina. Resultados: Dos 69 Staphylococcus coagulase negativo
testados, 71% foram mecA-positivos e 29%, mecA-negativos.
Todos os métodos testados apresentaram concordância esta-
tisticamente significante com a reação em cadeia da polime-
rase. Houve tendência à predominância da positividade da
reação em cadeia da polimerase entre os S. epidermidis com-
parado aos não-epidermidis, embora sem significância esta-
tistica (78,3% vs. 56,5%; χ2= 2,54; p=0,11). O teste de triagem
em ágar (0,75 µg oxacilina/ml) apresentou a melhor perfor-
mance com resultados de: 100% de sensibilidade e valor predi-
tivo negativo, 95% de especificidade e 98% de valor preditivo
positivo. Os isolados mecA-positivos foram estatisticamente
significativavos mais resistentes para ciprofloxacina, ofloxa-
cina, gatifloxacina e moxifloxacina, no E-test (p=0,002; p=0,008;
p=0,002 e p=0,003). Houve maior proporção estatisticamente
significativa de resistência entre os Staphylococcus coagu-
lase negativo mecA-positivos para: penicilina G, amoxicilina-
ampicilina, cefazolina, ampicilina-sulbactam, eritromicina, clin-
damicina, gentamicina e tetraciclina. (p<=0,05) Todos os Sta-
phylococcus coagulase negativos foram suscetíveis à vanco-
micina e não houve correlação estatisticamente significativa
entre as amostras mecA-positivas e a resistência para sulfame-
toxazol-trimetoprima e rifampicina. Conclusões: No presente
estudo, foi observado que o E-test e o OSAS (0,75 μg oxacilina
por ml), comparado à reação em cadeia da polimerase, foram os
métodos fenotípicos mais acurados em detectar a resistência à
oxacilina nos Staphylococcus coagulase negativos. Foi de-
monstrado que os testes de disco difusão com cefoxitina e o
método automatizado (Vitek) são boas opções para a triagem
da resistência à oxacilina em laboratórios de microbiologia
ocular. Destacou-se a importância de métodos acurados para
detectar a resistência à meticilina dentre as espécies menos
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freqüentemente encontradas, considerando a crescente im-
portância destes patógenos oportunistas.
Descritores: Resistência a meticilina; Sensibilidade e especifi-
cidade; Testes de fixação do látex; Oxacilina; Testes de sensibili-
dade microbiana; Staphylococcus/isolamento & purificação;
Coagulase; Infecções oculares bacterianas; Estudo comparativo
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